Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes.

ABSTRACT:

SUBMITTER: Galtier J 

PROVIDER: S-EPMC8590686 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature